Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement

Book description

This guide explains how to apply health economic evaluation techniques to both clinical trial and non-clinical trial data. Through a simple, applied approach using examples and SAS software, the book helps statisticians and researchers in health economics assess cost-effectiveness. It covers trial design, case report form design, quality of life measures, sample sizes, submissions to regulatory authorities for reimbursement, Markov models, cohort models, and decision trees. Examples and case studies are provided at the end of each chapter.

Table of contents

  1. Front Cover (1/3)
  2. Front Cover (2/3)
  3. Front Cover (3/3)
  4. Contents (1/2)
  5. Contents (2/2)
  6. Preface
  7. Author
  8. Acronyms
  9. Chapter 1: Introduction to Economic Evaluation (1/5)
  10. Chapter 1: Introduction to Economic Evaluation (2/5)
  11. Chapter 1: Introduction to Economic Evaluation (3/5)
  12. Chapter 1: Introduction to Economic Evaluation (4/5)
  13. Chapter 1: Introduction to Economic Evaluation (5/5)
  14. Chapter 2: Health Economic Evaluation Concepts (1/6)
  15. Chapter 2: Health Economic Evaluation Concepts (2/6)
  16. Chapter 2: Health Economic Evaluation Concepts (3/6)
  17. Chapter 2: Health Economic Evaluation Concepts (4/6)
  18. Chapter 2: Health Economic Evaluation Concepts (5/6)
  19. Chapter 2: Health Economic Evaluation Concepts (6/6)
  20. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (1/7)
  21. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (2/7)
  22. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (3/7)
  23. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (4/7)
  24. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (5/7)
  25. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (6/7)
  26. Chapter 3: Designing Cost-Effectiveness into a Clinical Trial (7/7)
  27. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (1/7)
  28. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (2/7)
  29. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (3/7)
  30. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (4/7)
  31. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (5/7)
  32. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (6/7)
  33. Chapter 4: Analysing Cost Data Collected in a Clinical Trial (7/7)
  34. Chapter 5: Quality of Life in Economic Evaluation (1/7)
  35. Chapter 5: Quality of Life in Economic Evaluation (2/7)
  36. Chapter 5: Quality of Life in Economic Evaluation (3/7)
  37. Chapter 5: Quality of Life in Economic Evaluation (4/7)
  38. Chapter 5: Quality of Life in Economic Evaluation (5/7)
  39. Chapter 5: Quality of Life in Economic Evaluation (6/7)
  40. Chapter 5: Quality of Life in Economic Evaluation (7/7)
  41. Chapter 6: Modelling in Economic Evaluation (1/6)
  42. Chapter 6: Modelling in Economic Evaluation (2/6)
  43. Chapter 6: Modelling in Economic Evaluation (3/6)
  44. Chapter 6: Modelling in Economic Evaluation (4/6)
  45. Chapter 6: Modelling in Economic Evaluation (5/6)
  46. Chapter 6: Modelling in Economic Evaluation (6/6)
  47. Chapter 7: Sensitivity Analyses (1/6)
  48. Chapter 7: Sensitivity Analyses (2/6)
  49. Chapter 7: Sensitivity Analyses (3/6)
  50. Chapter 7: Sensitivity Analyses (4/6)
  51. Chapter 7: Sensitivity Analyses (5/6)
  52. Chapter 7: Sensitivity Analyses (6/6)
  53. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (1/7)
  54. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (2/7)
  55. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (3/7)
  56. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (4/7)
  57. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (5/7)
  58. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (6/7)
  59. Chapter 8: Sample Size and Value of Information for Cost-Effectiveness Trials (7/7)
  60. Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (1/3)
  61. Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (2/3)
  62. Chapter 9: Mixed Treatment Comparisons, Evidence Synthesis (3/3)
  63. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (1/6)
  64. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (2/6)
  65. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (3/6)
  66. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (4/6)
  67. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (5/6)
  68. Chapter 10: Cost-Effectiveness Analyses of Cancer Trials (6/6)
  69. Chapter 11: The Reimbursement Environment (1/3)
  70. Chapter 11: The Reimbursement Environment (2/3)
  71. Chapter 11: The Reimbursement Environment (3/3)
  72. References (1/2)
  73. References (2/2)
  74. Bibliography (1/2)
  75. Bibliography (2/2)
  76. Back Cover

Product information

  • Title: Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
  • Author(s): Iftekhar Khan
  • Release date: November 2015
  • Publisher(s): Chapman and Hall/CRC
  • ISBN: 9781466505483